Regenerative medicine is a rapidly advancing field that has the potential to transform human health care. The potential now exists to develop tissue engineered constructs for tissue repair and organ replacement.  The US Dept. of Health and Human Services predicts that “within 20 years regenerative medicine will be the standard of care for replacing all tissue/organ systems in the body in addition to extensive industrial use for pharmaceutical testing.”  Organovo, Inc. is dedicated to applying its breakthrough organ printing technologies to make those goals a reality. Founded on innovative federally funded tissue engineering science, Organovo is developing proprietary technologies to deliver on the promise of a new era of medicine.